MRVI: Maravai LifeSciences Holdings, Inc. Stock

by  •  • Comments Off on MRVI: Maravai LifeSciences Holdings, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 1,167.36
Enterprise Value ($M) 1,489.68
Book Value ($M) 892.28
Book Value / Share 6.73
Price / Book 1.31
NCAV ($M) 2.35
NCAV / Share 0.02
Price / NCAV 497.60

Profitability (mra)
Return on Invested Capital (ROIC) -0.08
Return on Assets (ROA) -0.05
Return on Equity (ROE) -0.13

Liquidity (mrq)
Quick Ratio 7.41
Current Ratio 8.00

Balance Sheet (mrq) ($M)
Current Assets 699.91
Assets 1,487.45
Liabilities 697.57
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 288.94
Operating Income -28.47
Net Income -119.03

Cash Flow Statement (mra) ($M)
Cash From Operations 126.22
Cash from Investing -122.31
Cash from Financing -61.09

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-28 13G/A 12 West Capital Management LP 8.80 0.00
02-13 13G/A Vanguard Group Inc 7.57 -3.72
02-08 13G/A Maravai Life Sciences Holdings 2, Llc 56.02 -3.15
01-05 13G/A Millennium Management Llc 4.50 -13.89
11-07 13G/A Massachusetts Financial Services Co /ma/ 4.60 -53.57

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-02-29 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2023-11-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2023-08-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2023-05-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-05-03 286,610 1,660,644 17.26
2024-05-02 218,325 467,206 46.73
2024-05-01 239,351 493,543 48.50
2024-04-30 430,117 674,234 63.79
2024-04-29 274,117 497,124 55.14

(click for more detail)

Similar Companies
MNMD – Mind Medicine (MindMed) Inc. MRNA – Moderna, Inc.
MRSN – Mersana Therapeutics, Inc. MTEX – Mannatech, Incorporated
MYGN – Myriad Genetics, Inc.


Financial data and stock pages provided by
Fintel.io